New AHA/ASA Stroke Guidelines Stress t-PA, Telemedicine

Wendling, Patrice
March 2013
Neurology Reviews;Mar2013, Vol. 21 Issue 3, p19
The article focuses on new guidelines issued by the organizations American Health Association and the American Stroke Association for treating patients suffering from acute ischemic stroke. As mentioned, clinicians are advised to take a brain computed tomography (CT) scan or magnetic resonance imaging (MRI) before tissue plasminogen activator (t-PA) is administered. However, according to the guidelines glucose determination is the only requirement before fibrinolytics therapy is initiated.


Related Articles

  • Intra-arterial Therapy for Acute Stroke: Trials and Tribulations. Jayaraman, Mahesh V.; Haas, Richard A.; Ahn, Sun H. // Medicine & Health Rhode Island;Dec2011, Vol. 94 Issue 12, p357 

    The article examines the treatment of acute ischemic stroke with intra-arterial therapy (IAT). A brief history on the significance of thombolysis and thombectomy in the management of stroke is offered. The NINDS IV trial is highlighted which evaluates the effectivness of a tissue plasminogen...

  • Hyper-acute stroke treatment: the first 48 hours. Nazarko, Linda // British Journal of Healthcare Assistants;Oct2013, Vol. 7 Issue 10, p486 

    Every year, 150 000 people in the UK suffer a stroke. This works out at one every five minutes (Townsend et al, 2012). Stroke is the single largest cause of disability and the third largest cause of deaths in England. Stroke costs the NHS over £2.8 billion and can lead to death or severe...

  • Modified ASPECTS for DWI including deep white matter lesions predicts subsequent intracranial hemorrhage. Kawano, Hiroyuki; Hirano, Teruyuki; Nakajima, Makoto; Inatomi, Yuichiro; Yonehara, Toshiro; Uchino, Makoto // Journal of Neurology;Oct2012, Vol. 259 Issue 10, p2045 

    We hypothesized that extensive early ischemic changes increase subsequent intracranial hemorrhage (ICH) in patients within 3 h of onset regardless of intravenous tPA (IV-tPA). We have established a modified scoring method, ASPECTS+W, including deep white matter lesions on DWI (DWI-W) in addition...

  • Primary Stroke Center Concept: Strengths and Limitations. Chaudhry, F.; Schneck, M. J.; Warady, J.; Platakis, J.; Morales-Vidal, S.; Biller, J.; Flaster, M. // Frontiers in Neurology;Jun2012, Vol. 3, p1 

    The authors discuss the establishment of primary stroke centers (PSC) aimed at improving care of stroke patients in the U.S. They state that the PSC could treat patients and offer initial care such as intravenous thrombolytic therapy using tissue plasminogen activator (tPA). They explore the...

  • Thrombolytic Therapy in Acute Stroke: Outcome, Barriers & How to Overcome. AHASAN, HAM NAZMUL; HOSSAIN, YEANUR; DAS, APARNA; MINNAT, BAHARUL; CHOWDHURY, MOSTOFA KAMAL // Journal of Medicine;2013, Vol. 14 Issue 1, p65 

    The article discusses aspects on the use of thrombolytic therapy in treating acute stroke and examines the outcome and barriers of the treatment. Topics discussed include the mortality and prevalence of stroke, the use of recombinant tissue plasminogen activator (rt-PA), and the clinical use of...

  • Massive Hemothorax Following Thrombolysis With rtPA in a Stroke Patient With Undiagnosed Rib Fractures. Belzunegui, Tomas; Beaumont, Carlos; Louis, Clint Jean; Cabodevilla, Ana // Journal of Medical Cases;2013, Vol. 4 Issue 7, p447 

    The majority of strokes are of ischaemic origin. Thrombolysis has led to a radical change in the outcome of these patients as far as management and prognosis. The main objective is the opening up of the occluded artery and early reperfusion of brain tissue. Only 2% to 4% of patients with acute...

  • Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients. Chen, Yan; Li, Chen-hua; Wang, Yu-Xin; Zhang, Chen-Hao; Dong, Zhong; Zhang, Fang-fang; Wang, Jin-Huan; Zhang, Pei-Lan // Cell Biochemistry & Biophysics;Jul2015, Vol. 72 Issue 3, p883 

    This study aims to explore the safety and efficacy of intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) in elderly (≥80 years old) acute ischemic stroke (AIS) patients. The clinical data of patients who were treated in Tianjin Huanhu Hospital from June...

  • Improvement in Thrombolytic Therapy Administration in Acute Stroke with Feedback. Ghrooda, Esseddeeg; Alcock, Susan; Jackson, Alan C. // Canadian Journal of Neurological Sciences;Nov2012, Vol. 39 Issue 6, p789 

    Background: The benefits of intravenous recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke is time dependent. Guidelines recommend a door-to-needle (DTN) time of less than 60 minutes. Methods: A retrospective audit of 730 stroke charts from 2008 - 2011 was conducted at...

  • Orolinguales Angio�dem unter systemischer Thrombolyse mit rt-PA. Ottomeyer, C.; Sick, C.; Hennerici, M.G.; Szabo, K. // Nervenarzt;Apr2009, Vol. 80 Issue 4, p459 

    Background: Orolingual angioedema (OA) is an unappreciated complication of acute stroke treatment with recombinant tissue plasminogen activator (rt-PA). It has been described in 2% of patients receiving thrombolysis, and it seems that patients taking angiotensin-converting enzyme inhibitors are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics